RTW Investments’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-139,884
Closed -$26.9M 112
2020
Q3
$26.9M Sell
139,884
-101,904
-42% -$22.8M 0.65% 41
2020
Q2
$66.1M Sell
241,788
-2,615
-1% -$697K 1.86% 19
2020
Q1
$68.4M Buy
244,403
+2,778
+1% +$851K 2.94% 8
2019
Q4
$90M Buy
241,625
+105,543
+78% +$30.2M 3.4% 8
2019
Q3
$44.3M Buy
136,082
+21,919
+19% +$7.45M 2.64% 13
2019
Q2
$40.2M Buy
114,163
+17,679
+18% +$6.95M 2.15% 14
2019
Q1
$48.2M Buy
96,484
+5,734
+6% +$2.56M 3.29% 8
2018
Q4
$36.5M Buy
90,750
+66,588
+276% +$25.2M 3.35% 11
2018
Q3
$9.94M Buy
24,162
+11,582
+92% +$3.93M 0.6% 30
2018
Q2
$4.62M Buy
12,580
+80
+0.6% +$28.6K 0.33% 31
2018
Q1
$4.21M Buy
+12,500
New +$4.2M 0.4% 32

Other funds holding QTTB

RTW Investments's QTTB Position: Q4 2020 in Review

RTW Investments sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 139,884 shares — an estimated $26.9M sold.

RTW Investments first reported a position in QTTB in Q1 2018 and held it in 11 quarters. The position peaked at $90M in Q4 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

  • RTW Investments reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
  • RTW Investments sold 139,884 Q32 Bio shares in Q4 2020, an estimated $26.9M.
  • RTW Investments first reported a position in Q32 Bio in Q1 2018 and held it in 11 quarters.
  • RTW Investments's Q32 Bio position peaked at $90M in Q4 2019.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on RTW Investments's 13F filing for Q4 2020, filed 16 Feb 2021.